Search

everythinglearnresearchcommunity

for

Search:↓

During puberty, hormone levels rise, with early increases in some steroids and most menstrual cycles becoming regular by six years after menarche.

The document concludes that hirsutism in women, often caused by PCOS, requires systematic evaluation and can be treated with medications, mechanical removal, or cosmetic methods, with weight loss also being beneficial.

Hirsutism in females is complex, often linked to tumors, and requires more research for better treatment.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Spironolactone helps reduce hair growth in women with hirsutism but may cause menstrual irregularities.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

Both cyproterone acetate and spironolactone effectively reduce hair growth in women with hirsutism.

Finasteride helps treat hair loss and prostate issues by blocking a hormone.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Early androgen exposure affects hormone receptor expression in adult female rats' brains, but not in males.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

A Saudi individual initially identified as a girl had a genetic disorder affecting gender development.

Finasteride is an effective and well-tolerated treatment for hirsutism.

The study created a new method to test drugs that affect hormone processing in skin.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Genetics may play a significant role in gender dysphoria.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Effective hirsutism treatment for women with PCOS should be personalized and may include lifestyle changes and medication.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.